Hillsdale Investment Management Inc. Gilead Sciences, Inc. Transaction History

Hillsdale Investment Management Inc.

$1.21 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $585,400 - $675,597	9,270 Added 5793.75%	9,430 $646,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $29,601 - $33,568	-404 Reduced 71.63%	160 $12,000
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $578,654 - $631,323	-7,826 Reduced 93.28%	564 $42,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $34,964 - $39,882	460 Added 5.8%	8,390 $646,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $126,015 - $143,570	1,630 Added 25.87%	7,930 $657,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $137,104 - $196,834	-2,200 Reduced 25.88%	6,300 $540,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $490,620 - $552,585	8,500 New	8,500 $525,000
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $6,430 - $6,937	-95 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $410,968 - $449,041	-6,475 Reduced 98.55%	95 $7,000
Q1 2021 Apr 22, 2021	BUY	$60.0 - $68.46 $6,000 - $6,845	100 Added 1.55%	6,570 $425,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $30,024 - $34,211	-530 Reduced 7.57%	6,470 $377,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $69,206 - $88,643	-1,105 Reduced 13.63%	7,000 $524,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $12,324 - $13,556	200 Added 2.53%	8,105 $526,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $20,940 - $23,115	335 Added 4.43%	7,905 $501,000
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $55,683 - $62,441	900 Added 13.49%	7,570 $512,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $130,062 - $145,704	2,080 Added 45.32%	6,670 $434,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $42,378 - $55,300	-700 Reduced 13.23%	4,590 $287,000
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $1,297 - $1,513	-20 Reduced 0.38%	5,290 $375,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $14,568 - $17,760	-200 Reduced 3.63%	5,310 $400,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $50,477 - $59,829	700 Added 14.55%	5,510 $447,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,810	4,810 $341,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Account